Arming Tumor-Associated Macrophages to Reverse Epithelial Cancer Progression by Wettersten, Hiromi I, Weis, Sara M, Pathria, Paulina, Von Schalscha, Tami, Minami, Toshiyuki, Varner, Judith A, Cheresh, David A

Get full text

Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma by Cosset, Érika, Ilmjärv, Sten, Dutoit, Valérie, Elliott, Kathryn, von Schalscha, Tami, Camargo, Maria F., Reiss, Alexander, Moroishi, Toshiro, Seguin, Laetitia, Gomez, German, Moo, Jung-Soon, Preynat-Seauve, Olivier, Krause, Karl-Heinz, Chneiweiss, Hervé, Sarkaria, Jann N., Guan, Kun-Liang, Dietrich, Pierre-Yves, Weis, Sara M., Mischel, Paul S., Cheresh, David A.

Get full text

Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers by Seguin, Laetitia, Camargo, Maria F, Wettersten, Hiromi I, Kato, Shumei, Desgrosellier, Jay S, von Schalscha, Tami, Elliott, Kathryn C, Cosset, Erika, Lesperance, Jacqueline, Weis, Sara M, Cheresh, David A

Get full text

Disruption of Angiogenesis by PEX, a Noncatalytic Metalloproteinase Fragment with Integrin Binding Activity by Brooks, Peter C, Silletti, Steve, von Schalscha, Tami L, Friedlander, Martin, Cheresh, David A

Get full text

Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 by Brooks, Peter C, Strömblad, Staffan, Sanders, Luraynne C, von Schalscha, Tami L, Aimes, Ronald T, Stetler-Stevenson, William G, Quigley, James P, Cheresh, David A

Get full text

Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer by Testa, Anna, Quaglia, Fabio, Naranjo, Nicole M, Verrillo, Cecilia E, Shields, Christopher D, Lin, Stephen, Pickles, Maxwell W, Hamza, Drini F, Von Schalscha, Tami, Cheresh, David A, Leiby, Benjamin, Liu, Qin, Ding, Jianyi, Kelly, William K, Hooper, D Craig, Corey, Eva, Plow, Edward F, Altieri, Dario C, Languino, Lucia R

Get full text

PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections by Shepard, Ryan M, Ghebremedhin, Anghesom, Pratumchai, Isaraphorn, Robinson, Sally R, Betts, Courtney, Hu, Jingjing, Sasik, Roman, Fisch, Kathleen M, Zak, Jaroslav, Chen, Hui, Paradise, Marc, Rivera, Jason, Amjad, Mohammad, Uchiyama, Satoshi, Seo, Hideya, Campos, Alejandro D, Dayao, Denise Ann, Tzipori, Saul, Piedra-Mora, Cesar, Das, Soumita, Hasteh, Farnaz, Russo, Hana, Sun, Xin, Xu, Le, E Alexander, Laura Crotty, Duran, Jason M, Odish, Mazen, Pretorius, Victor, Kirchberger, Nell C, Chin, Shao-Ming, Von Schalscha, Tami, Cheresh, David, Morrey, John D, Alargova, Rossitza, O'Connell, Brenda, Martinot, Theodore A, Patel, Sandip P, Nizet, Victor, Martinot, Amanda J, Coussens, Lisa M, Teijaro, John R, Varner, Judith A

Get full text

Abstract 3067: Galectin-3, a target for KRAS-addicted lung cancer by Seguin, Laetitia, Camargo, Maria F., Wettersten, Hiromi I., Kato, Shumei, Schalscha, Tami von, Elliott, Kathryn C., Weis, Sara M., Cheresh, David A.

Get full text

A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer by Delaney, Joe R, Patel, Chandni, McCabe, Katelyn E, Lu, Dan, Davis, Mitzie-Ann, Tancioni, Isabelle, von Schalscha, Tami, Bartakova, Alena, Haft, Carley, Schlaepfer, David D, Stupack, Dwayne G

Get full text